StayCurrentMD · Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus
Follow
Video1 min·Published Aug 2023Older

Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus

hosted by Dr. Cecilia Gigena

Chapter 1 of 1 · Evidence & Research

PDA management trial

Non-inferiority trial of expectant management versus early ibuprofen for PDA in preterm infants

Try
Intelligent Search· scoped to patent ductus arteriosus · not medical adviceSearch the whole library →
What the experts said0 expert statements · 10 host summaries
A multi-center non-inferiority trial compared preterm infants treated with expectant management versus early ibuprofen for PDA
Host summaryCecilia Gigena summarizing a resource · not cited in answers
The trial enrolled 273 infants total
Host summaryCecilia Gigena summarizing a resource · not cited in answers
136 infants were treated with expectant management and 137 with early ibuprofen
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the expectant management group, 17.6% developed necrotizing enterocolitis
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the expectant management group, 33% developed bronchopulmonary dysplasia
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the expectant management group, the death rate was 14%
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the ibuprofen group, 15.4% developed necrotizing enterocolitis
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the ibuprofen group, 50% developed bronchopulmonary dysplasia
Host summaryCecilia Gigena summarizing a resource · not cited in answers
In the ibuprofen group, the death rate was 80%
Host summaryCecilia Gigena summarizing a resource · not cited in answers
Expectant management is non-inferior to early ibuprofen in preterm patients with PDA
Host summaryCecilia Gigena summarizing a resource · not cited in answers